REVAGENIX
Revagenix is a biopharmaceutical company discovering and developing therapies to address medical needs.
REVAGENIX
Industry:
Biotechnology Pharmaceutical Service Industry
Founded:
2019-01-01
Address:
San Mateo, California, United States
Country:
United States
Website Url:
http://www.revagenix.com
Total Employee:
1+
Status:
Active
Contact:
(650) 228-3244
Current Employees Featured
Official Site Inspections
http://www.revagenix.com
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Revagenix"
Revagenix
Sep 26, 2023 · Our mission at Revagenix is to create life-changing antibiotics. We're passionate about moving the needle on the tens of thousands of deaths every year due to drug-resistant …See details»
Why and how we built Revagenix
Our mission at Revagenix is to create life-changing antibiotics. That means: Assembling a highly driven, and versatile team with deep insights into the space, an ownership mentality, and decades of experience in anti-infective research, …See details»
Team - Revagenix
Revagenix leverages a lean team to deliver results equivalent to a company several times our size. Through a world-class network of strategic collaborators, partners, investors, and …See details»
Revagenix - Crunchbase Company Profile & Funding
Revagenix is a biopharmaceutical company discovering and developing therapies to address medical needs. Revagenix may be growing as it has announced a Series B financing round, which is typically a significant indicator of investor …See details»
Revagenix Company Profile 2024: Valuation, Funding & Investors
Operator of a biotechnology research company intended to discover and develop novel therapies. The company's biopharmaceuticals include anti-infective medicines to ensure meaningful …See details»
Revagenix, Inc. - LinkedIn
Revagenix exists to deliver urgently needed anti-infective medicines to patients around the world. We are hiring! If you or someone you know are interested, please apply through the link....See details»
Revagenix, Inc. | Devex
Learn more about Revagenix, Inc.'s jobs, projects, latest news, contact information and geographical presence. Revagenix exists to deliver urgently needed anti-infective medicines to …See details»
Revagenix - Funding, Financials, Valuation & Investors - Crunchbase
Revagenix is a biopharmaceutical company discovering and developing therapies to address medical needs.See details»
Revagenix - Contacts, Employees, Board Members, Advisors
Revagenix is a biopharmaceutical company discovering and developing therapies to address medical needs.See details»
Revagenix, Inc. Company Profile | San Mateo, CA | Competitors ...
Find company research, competitor information, contact details & financial data for Revagenix, Inc. of San Mateo, CA. Get the latest business insights from Dun & Bradstreet.See details»
Ryan Cirz – REVIVE
Ryan Cirz is Chief Scientific and acting Chief Executive Officer of Revagenix, Inc. a biotechnological company focused on antibacterial R&D. Previously, he was founder and vice President of Research at Achaogen.See details»
Revagenix, Inc. Announces Series B Financing to Develop Novel ...
Jan 5, 2024 · Revagenix is dedicated to creating life-changing antibiotics, providing urgently needed anti-infective medicines to patients globally. We are advancing a focused pipeline …See details»
Contact - Revagenix
Passionate job-seekers, academics, investors, deal-makers, and other members of the life science ecosystem can get in touch with us below.See details»
Revagenix, Inc. Announces Series B Financing to Develop Novel ...
Jan 5, 2024 · Revagenix, Inc. is advancing a focused pipeline of antibiotic programs designed to treat infections caused by multidrug-resistant organismsSee details»
Revagenix - Overview, News & Similar companies | ZoomInfo.com
Who is Revagenix. Revagenix is dedicated to creating life-changing antibiotics, providing urgently needed anti-infective medicines to patients globally. We are advan cing a focused pipeline …See details»
Revagenix, Inc. Announces Series B Financing to Develop Novel ...
Jan 5, 2024 · Revagenix, Inc., a biopharmaceutical company dedicated to the discovery and development of novel antibiotics, today announced the appointment of Cristina Larkin, Bruce …See details»
Revagenix - Products, Competitors, Financials, Employees, …
Revagenix focuses on the development of anti-infective medicines, operating within the biopharmaceutical industry. Use the CB Insights Platform to explore Revagenix's full profile.See details»
Media - Revagenix
Jan 5, 2024 · Whether it’s nucleating the Antimicrobial Innovation Alliance (AIA), or engaging with journalists to raise awareness of the antimicrobial resistance crisis, the Revagenix team is on …See details»
Revagenix - REPAIR Impact Fund
Innovative drug design to address MDR and PDR pathogens. Revagenix is a preclinical-stage biopharmaceutical company dedicated to the discovery and development of life-changing and …See details»
Pipeline - Revagenix
Revagenix is advancing a proprietary pipeline of highly differentiated antibiotic programs in late preclinical stage, each with life-changing potential. Our product profiles are thoughtfully …See details»